467
Views
1
CrossRef citations to date
0
Altmetric
Open Peer Commentaries

Ending the War on People with Substance Use Disorders in Health Care

&

REFERENCES

  • Beetham, M., B. Saloner, M. Gaye, S. E. Wakeman, R. G. Frank, and M. L. Barnett. 2021. Admission practices and cost of care for opioid use disorder at residential addiction treatment programs in the US. Health Affairs (Project Hope) 40 (2):317–25. doi:10.1377/hlthaff.2020.00378.
  • Dineen, K. K. 2021. It’s not the patient, it’s the system. Journal of Addiction Medicine. doi:10.1097/ADM.0000000000000800.
  • Dineen, K. K., and A. Ruggles. 2018. Legal regulation of opioid prescribing. In Prescription drug diversion and pain: History, policy and treatment, ed. J. J. Peppin, J. Coleman, K. K. Dineen, and A. Ruggles. Oxford: Oxford University Press.
  • Dineen, K. K., and E. Pendo. 2021. Substance use disorder discrimination and the CARES Act: Using disability law to guide part 2 rulemaking. Arizona State Law Journal 52:1143–65.
  • Earp, B. D., J. Lewis, and C. L. Hart. 2021. Racial justice requires ending the war on drugs. The American Journal of Bioethics 21 (4):4–19. doi:10.1080/15265161.2020.1861364.
  • Kuo, Y., M. A. Raji, and J. S. Goodwin. 2019. Association of disability with mortality from opioid overdose among US Medicare adults. JAMA Network Open 2 (11):e1915638. doi:10.1001/jamanetworkopen.2019.15638.
  • Mendoza, S., A. S. Rivera, and H. B. Hansen. 2019. Re-racialization of addiction and the redistribution of blame in the white opioid epidemic. Medical Anthropology Quarterly 33 (2):242–62. doi:10.1111/maq.12449.
  • National Academies of Sciences, Engineering, and Medicine. 2019. Medications for opioid use disorder save lives. Washington, DC: The National Academies Press.
  • Ray, K. S. 2021. It's time for a black bioethics. The American Journal of Bioethics 21 (2):38–40. doi:10.1080/15265161.2020.1861381.
  • Substance Abuse and Mental Health Services Administration (SAMSHA). 2020. Key substance use and mental health indicators in the United States: Results from the 2019 national survey on drug use and health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/.
  • Tsai, A. C., M. V. Kiang, M. L. Barnett, L. Beletsky, K. M. Keyes, E. E. McGinty, L. R. Smith, S. A. Strathdee, S. E. Wakeman, A. S. Venkataramani, et al. 2019. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Medicine 16 (11):e1002969. doi:10.1371/journal.pmed.1002969.
  • Wakeman, S. E., and J. D. Rich. 2018. Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse 53 (2):330–3. doi:10.1080/10826084.2017.1363238.
  • Yearby, R. 2021. Race based medicine, colorblind disease: How racism in medicine harms us all. The American Journal of Bioethics 21 (2):19–27. doi:10.1080/15265161.2020.1851811.
  • Yearby, R., and S. Mohapatra. 2020. Law, structural racism, and the COVID-19 pandemic. Journal of Law and the Biosciences 7 (1):lsaa036. doi:10.1093/jlb/lsaa036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.